Pages

▼

1 to 3% of all couples experience recurrent pregnancy loss

›
Approximately 1--3% of all couples experience recurrent pregnancy loss, and about 50-70% of all conceptions fail. The underlying molecular m...

Single embryo transfer, a new understanding of factors for success

›
Transferring a single embryo to a woman can result in a similar number of pregnancies as double embryo transfer, while at the same time redu...

Trends in smoking in Great Britain

›
Smoking prevalence in the UK has fallen steadily over the last two decades. In 2000, 27% of adults aged 16 and over in Great Britain smoked ...

European regulators extend missed pill window for Cerazette, Contraceptive without estrogen

›
The 'missed pill window' for Cerazette, the estrogen-free contraceptive pill, has been extended from 3 to 12 hours, following an agr...

Doctors urged to keep check on daughters of women who used pregnancy drug three decades ago Australia

›
Women whose mothers took a synthetic oestrogen called Stilboestrol, known also as Diethylstilboestrol (DES) during pregnancy some three or f...

Protecting women against rubella: Guidance on the use of MMR vaccine

›
Rubella (German measles) is a mild illness in most people but if caught in the early stages of pregnancy, it can severely damage the unborn ...

Serono receives FDA approval for Gonal-f RFF Pen to treat infertility

›
First and only prefilled device with new liquid formulation developed to make infertility treatment more convenient for patients. Serono, ...